Alzheimer's & Cognition
This is the first drug approved for imaging tau pathology, one of the two neuropathologic hallmarks of Alzheimer’s disease.
One of two “identical studies” assessing a novel treatment in development for Alzheimer’s disease reports significant efficacy, while the other...
“Certainly the appalling number of deaths in nursing homes is the No. 1 horror of the pandemic.”
When assessing altered mental status, consider COVID-19 in your differential diagnosis.
“In the absence of effective treatments for dementia, we need to monitor and control cardiovascular risk burden as a way to maintain patient’s...
“These findings have the potential to inform public health strategies to reduce the burden of dementia globally.”
Knowing the expected prevalence of such incidental findings in the older general population is “extremely useful” for both researchers and...
Proposed mechanisms for cognitive decline in patients with systolic dysfunction include low cardiac output, embolic infarctions, and hypoxic...
From the Journals
A cognition survey of more than 22,000 FOURIER patients showed no compromise linked to evolocumab or sharply cut LDL-C levels.
“What is good for the heart is also good for the brain.”
New genetic insights may better predict who may become symptomatic from the disease and help develop targets for treatment.